Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.28%
#4 aPriori aPriori +133.46%
#5 Bedrock Bedrock +71.29%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.40%
#8 Playnance Playnance +35.05%
#9 COTI COTI +29.45%
#10 Bitway Bitway +24.50%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Rank in Stocks #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Share Price
$0.85
Last synced: 2025-01-21
Market Cap
$411.40
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Fresh2 Group Limited (FRES)

Category

Healthcare
P/B ratio for Fresh2 Group Limited (FRES)
P/B ratio as of August 2026 TTM: 0.00
According to Fresh2 Group Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0.00. At the end of 2021 the company had a P/B ratio of -0.12.
P/B ratio history for Fresh2 Group Limited from 2017 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 0.00 -98.00%
2022 -0.02 -80.73%
2021 -0.12 -117.83%
2020 0.66 -358.77%
2019 -0.25 43.70%
2018 -0.18 -145.57%
2017 0.39 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -1,565,425.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -1,587,175.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -908,600.00%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR